Therefore, this study reveals that SEC61G promotes NSCLC brain metastases by stabilizing PGAM1, driving glycolytic metabolic reprogramming, and remodeling the immune microenvironment through lactate production. Here, SEC61G is linked to non-small cell lung carcinoma.